Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections
Open accessThe DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Abstract
Lactoferrin (Lf) is a glycoprotein of the primary innate immune-defense system of mammals present in milk and other mucosal secretions. This protein of the transferrin family has broad antimicrobial properties by depriving pathogens from iron, or disrupting their plasma membranes through its highly cationic charge. Noteworthy, Lf also exhibits immunomodulatory activities performing up- and down-regulation of innate and adaptive immune cells, contributing to the homeostasis in mucosal surfaces exposed to myriad of microbial agents, such as the gastrointestinal and respiratory tracts. Although the inflammatory process is essential for the control of invasive infectious agents, the development of an exacerbated or chronic inflammation results in tissue damage with life-threatening consequences. In this review, we highlight recent findings in in vitro and in vivo models of the gut, lung, oral cavity, mammary gland, and liver infections that provide experimental evidence supporting the therapeutic role of human and bovine Lf in promoting some parameters of inflammation and protecting against the deleterious effects of bacterial, viral, fungal and protozoan-associated inflammation. Thus, this new knowledge of Lf immunomodulation paves the way to more effective design of treatments that include native or synthetic Lf derivatives, which may be useful to reduce immune-mediated tissue damage in infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“lactoferrin can modulate GI inflammation by helping resolve the infection and prevent tissue damage along with reducing the growth of pathogens [49].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [49]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Data to determine if lactoferrin can reduce iron-induced GI side effects is ambiguous, but lactoferrin can modulate GI inflammation by helping resolve the infection and prevent tissue damage along with reducing the growth of pathogens [49].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [49]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942 · cited 2×
“Some PRRs comprise a large family of receptors such as Toll-like receptors (TLRs) [90] [91] [92] .”
Respiratory epithelial cells orchestrate pulmonary innate immunity
Whitsett, J. A., & Alenghat, T. (2015) · Nature Immunology · doi:10.1038/ni.3045 · Cited by 801 · cited 1×
“Delivery of life-requiring oxygen to the systemic circulation and organs implies the potential incorporation of countless particles, toxicants and microbes, which are countered by local innate and adaptive immune responses that avoid their entry into the lung tissue and circulation and protect the lung structure and f…”
Lactoferrin: molecular structure and biological function
Lönnerdal, B., & Iyer, S. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.000521 · Cited by 781
Lactoferrin: a general review.
Levay, P., & Viljoen, M. (1995) · PubMed · Cited by 781
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745 · cited 2×
“Sepsis is a life-threatening syndrome that results by the harmful effects of inflammatory response associated to gut systemic infections [140,144,145].”
Lactoferrin—a multifunctional protein with antimicrobial properties
Farnaud, S., & Evans, R. W. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00152-4 · Cited by 738 · cited 1×
“Mechanisms underlying the antimicrobial action of Lf result from both direct (microbiostatic and/or microbicidal) and indirect (immunomodulatory) effects [3] [4] [5] .”
Converging roles of caspases in inflammasome activation, cell death and innate immunity
Man, S. M., & Kanneganti, T.-D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.7 · Cited by 701 · cited 1×
“Besides to generate active pro-inflammatory cytokines, some inflammasomes regulate cell death in response to microbial and endogenous danger signals [90] [91] [92] [93] .”
LACTOFERRIN, AN IRON-BINBING PROTEIN NI NEUTROPHILIC LEUKOCYTES
Masson, P. L., Heremans, J. F., & Schonne, E. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.3.643 · Cited by 700
Sepsis: Current Dogma and New Perspectives
Deutschman, C. S., & Tracey, K. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.001 · Cited by 677 · cited 1×
“Sepsis is a life-threatening syndrome that results by the harmful effects of inflammatory response associated to gut systemic infections [140,144,145].”
Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces
Corthésy, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00185 · Cited by 674
Research works printed but not linked: 3
- Ordaz-Pichardo, C.; Leon-Sicairos, N.; Canizales-Román, A.; Cornejo-Cortés, M.; Ortiz-Estrada, G.; de la Garza, M. Lactoferrin: A protein of the innate immune system capable of killing parasitic protozoa. In Parasites: Ecology, Diseases and Management; Erzinger, G.S., Ed.; Nova Science Publishers Inc.: Hauppauge, NY, USA, 2013; pp. 177-213.
- Leon-Sicairos, N.; Reyes-López, M.; Ordaz-Pichardo, C.; de la Garza, M. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica. Biochem. Cell Biol. 2006, 84, 327-336. [PubMed]
- Nazmi, 2012, Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection, Biochem. Biol., 411, 405
Cited by
Lactoferrin: Structure, function, denaturation and digestion
Wang, B., Timilsena, Y. P., Blanch, E., & Adhikari, B. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1381583 · Cited by 514
Cardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action
Cutone, A., Rosa, L., Ianiro, G., Lepanto, M. S., Bonaccorsi di Patti, M. C., Valenti, P., & Musci, G. (2020) · Biomolecules · doi:10.3390/biom10030456 · Cited by 210
Lactoferrin from Bovine Milk: A Protective Companion for Life
Superti, F. (2020) · Nutrients · doi:10.3390/nu12092562 · Cited by 204
The Lactoferrin Phenomenon—A Miracle Molecule
Kowalczyk, P., Kaczyńska, K., Kleczkowska, P., Bukowska-Ośko, I., Kramkowski, K., & Sulejczak, D. (2022) · Molecules · doi:10.3390/molecules27092941 · Cited by 180
Metadata
- Authors
- Drago-Serrano, M., Campos-Rodríguez, R., Carrero, J., & De la Garza, M.
- Affiliations
- Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Unidad Xochimilco (UAM-X), CdMx 04960, Mexico
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional (ESM-IPN), CdMx 11340, Mexico
- Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (MX)
- Departamento de Biología Celular, Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), CdMx 07360, Mexico
- Corresponding author
- Carrero, Julio
- ORCID
- Carrero, Julio
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-03-01
- Volume
- 18
- Issue
- 3
- Pages
- 501
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5372517
- OpenAlex
- W2593907163
- Cited by
- 151
- References
- 189
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 17 · 2023: 18 · 2022: 18 · 2021: 26 · 2020: 21 · 2019: 15 · 2018: 11 · 2017: 2
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Consejo Nacional de Ciencia y Tecnología (167788, IN206316)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- lactoferrin, inflammation, immunomodulation, innate immunity, antimicrobial activity, iron sequestration, mucosal immunity, intestinal infection, pulmonary infection, oral infection, mammary gland infection, liver infection, chronic inflammation, tissue damage, bacterial infection, viral infection, fungal infection, protozoan infection
- MeSH terms
- Animals, Anti-Infective Agents, Anti-Inflammatory Agents, Communicable Diseases, Humans, Immunity, Innate, Immunologic Factors, Inflammation, Lactoferrin, Immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
